Logo-bi
Original Research

1. An in vitro ethnopharmacological study on Prangos ferulacea: a wound healing agent
Keyvan Yousefi, Sanaz Hamedeyazdan, Darya Hodaei, Farzaneh Lotfipour, Behzad Baradaran, Mona Orangi, Fatemeh Fathiazad*
Bioimpacts. 2017;7(2): 75-82. doi: 10.15171/bi.2017.10
PMCID: PMC5524988     PMID: 28752071     Scopus ID: 85027462494    
Article
PDF
Full Text
XML
Cited By:
22
5
17
Original Research

2. CRISPRi-mediated knock-down of PRDM1/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells

Mohammad Azadbakht ORCID, Ali Sayadmanesh, Naghme Nazer, Amirhossein Ahmadi, Sara Hemmati, Hoda Mohammadzade, Marzieh Ebrahimi, Hossein Baharvand, Babak Khalaj, Mahmoud Reza Aghamaali* ORCID, Mohsen Basiri* ORCID
BioImpacts. 2022;12(4): 337-347. doi: 10.34172/bi.2021.23522
PMCID: PMC9376159     PMID: 35975204     Scopus ID: 85137404752    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
2
0
1
PRDM1/BLIMP1 expression is increased during differentiation from naïve to effector T cell.CRISPRi-mediated suppression of this transcription factor in ex vivo-expanded primary human T cellsresulted in increased central memory phenotype in human T cells.
Original Article

3. Autophagy induced macrophages by α-alumina(α-AL2O3) conjugated cysteine peptidase, enhances the cytotoxic activity of CD8+ T lymphocytes against Leishmania major
Fatemeh Beyzay ORCID, Ahamad Zavaran Hosseini* ORCID, Ali Hazrati, Mozhdeh Karimi, Sara Soudi* ORCID
Bioimpacts. 2023;13(5): 393-403. doi: 10.34172/bi.2023.25282
PMCID: PMC10509742     PMID: 37736336     Scopus ID: 85172771576    
Article
PDF
Full Text
XML
Cited By:
0
0
1
Review

4. The application, safety, and future of ex vivo immune cell therapies and prognosis in different malignancies
Katelyn R. Einloth ORCID, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden* ORCID
Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521
PMCID: PMC10676524     PMID: 38022382     Scopus ID: 85172806877    
Article
PDF
Full Text
XML
Cited By:
1
0
2
Original Article

5. Thalidomide augments maturation and T helper 1-inducing capacity of monocyte-derived dendritic cells in vitro
Mohsen Abbaszadeh ORCID, Bahar Naseri, Javad Masoumi, Elham Baghbani, Behzad Baradaran, Mohammad Reza Sadeghi* ORCID
Bioimpacts. 2025;15: 30588 | Published on: 2024 Dec 29. doi: 10.34172/bi.30588
PMCID: PMC12008494     PMID: 40256218     Scopus ID: 85217917946    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Review

6. CAR-T cell therapy as an approach for pediatric hematological malignancies in regenerative therapy: Current status and clinical outcomes
Xiaoman Guo* ORCID, Xueyin Jiang ORCID, Juan Zhang ORCID
Bioimpacts. 2025;15: 31459 | Published on: 2025 Oct 14. doi: 10.34172/bi.31459
Article
PDF
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons